BackPalisade Bio Overview

Palisade Bio Long Term Debt

Track Palisade Bio's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average

Loading

Palisade Bio Long Term Debt History

Loading

Palisade Bio vs. peers: Long Term Debt Comparison

Loading

Palisade Bio Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Palisade Bio (PALI) FAQ

Palisade Bio (PALI) currently reports a long-term debt of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Palisade Bio's long-term debt history and peer comparisons.

Palisade Bio's long-term debt changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Palisade Bio reported $0 in long-term debt as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Palisade Bio, and consider following PALI for alerts when major investors trade the stock.

Palisade Bio is classified in the Healthcare sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PALI with unrelated industries.